-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$48.60-13.6% Downside
Rhythm Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. has been rated by research analysts at H.C. Wainwright, JMP Securities, Needham, Goldman Sachs, Stifel Nicolaus in the past 90 days.